Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals (JAZZ) Financial Statements


Jazz Pharmaceuticals Financial Overview

Jazz Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.643; its P/E ratio is -48.77; Jazz Pharmaceuticals is scheduled to report earnings on August 8, 2023, and the estimated EPS forecast is $4.50. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 892.81M$ 972.12M$ 940.65M$ 932.88M$ 813.72M
Gross Profit$ 764.17M$ 804.76M$ 806.99M$ 808.67M$ 698.44M
EBIT$ 128.24M$ -265.87M$ 20.11M$ 84.20M$ 77.01M
EBITDA$ 278.03M$ -128.48M$ 168.94M$ 240.41M$ 256.72M
Net Income Common Stockholders$ 69.42M$ -240.72M$ -19.65M$ 34.66M$ 1.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.17B$ 881.48M$ 899.36M$ 771.26M$ 490.83M
Total Assets$ 11.04B$ 10.84B$ 10.38B$ 11.20B$ 11.77B
Total Debt$ 5.80B$ 5.81B$ 5.81B$ 6.11B$ 6.12B
Net Debt$ 4.63B$ 4.92B$ 4.92B$ 5.34B$ 5.63B
Total Liabilities$ 7.72B$ 7.76B$ 7.64B$ 8.00B$ 8.16B
Stockholders Equity$ 3.34B$ 3.09B$ 2.75B$ 3.20B$ 3.61B
Cash Flow-
Free Cash Flow$ 315.89M$ 332.59M$ 422.89M$ 221.61M$ 171.69M
Operating Cash Flow$ 319.71M$ 341.97M$ 417.99M$ 303.04M$ 208.98M
Investing Cash Flow$ -4.82M$ -324.38M$ 4.60M$ -89.16M$ -37.29M
Financing Cash Flow$ -28.79M$ 19.60M$ -289.05M$ 10.78M$ -270.81M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

Jazz Pharmaceuticals Debt to Assets

Jazz Pharmaceuticals Cash Flow

Jazz Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis